Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | JAZZ | RGEN | ||
| Company | Exact Sciences Cor | Jazz Pharma Plc | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 45.18 | 139.92 | 144.61 | ||
| High | 45.18 | 140.90 | 147.61 | ||
| Low | 43.75 | 138.34 | 139.07 | ||
| Last | 44.92 | 139.51 | 144.34 | ||
| Change | -0.26 | -0.71 | -8.47 | ||
| % Change | -0.58% | -0.51% | -5.54% | ||
| Volume | 1,862,600 | 637,000 | 1,160,800 | ||
| 20-Day Average Volume | 2,545,345 | 1,049,620 | 810,575 | ||
| Previous Close | 45.18 | 140.22 | 152.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.37 | 138.59 | 154.03 | ||
| 20-Day Raw Stochastic | 29.04% | 39.24% | 25.98% | ||
| 20-Day Relative Strength | 37.96% | 58.80% | 44.64% | ||
| Weighted Alpha | -28.15 | +23.39 | -21.27 | ||
| Today's Opinion | 88% Sell | 100% Buy | 8% Sell | ||
| Previous Opinion | 88% Sell | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.11% since 03/11/25 | +1.94% since 03/11/25 | -1.90% since 03/11/25 | ||
| Low | 42.06 on 03/13/25 | 133.99 on 03/12/25 | 139.07 on 03/18/25 | ||
| High | 46.99 on 03/12/25 | 140.94 on 03/17/25 | 153.89 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -9.49% since 02/18/25 | +3.04% since 02/18/25 | -0.58% since 02/18/25 | ||
| Low | 42.06 on 03/13/25 | 133.99 on 03/12/25 | 135.68 on 03/10/25 | ||
| High | 51.91 on 02/24/25 | 148.06 on 02/26/25 | 169.00 on 02/20/25 | ||
| 3-Month | |||||
| %Chg | -21.71% since 12/18/24 | +14.60% since 12/18/24 | -2.04% since 12/18/24 | ||
| Low | 42.06 on 03/13/25 | 118.72 on 01/10/25 | 135.68 on 03/10/25 | ||
| High | 60.88 on 01/13/25 | 148.06 on 02/26/25 | 182.52 on 01/28/25 | ||
| 6-Month | |||||
| %Chg | -35.10% since 09/18/24 | +27.33% since 09/18/24 | +1.63% since 09/18/24 | ||
| Low | 42.06 on 03/13/25 | 106.21 on 10/10/24 | 121.52 on 11/15/24 | ||
| High | 72.83 on 11/05/24 | 148.06 on 02/26/25 | 182.52 on 01/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,344,115 | 8,472,720 | 8,104,545 | ||
| Shares Outstanding, K | 185,755 | 60,732 | 56,149 | ||
| Annual Sales | 2,758,870,000 | 4,068,950,000 | 634,440,000 | ||
| Annual Net Income | -1,028,860,000 | 560,120,000 | -25,510,000 | ||
| Last Quarter Sales | 713,420,000 | 1,088,170,000 | 174,150,000 | ||
| Last Quarter Net Income | -864,590,000 | 191,120,000 | -30,280,000 | ||
| 60-Month Beta | 1.25 | 0.44 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/19/25 | 6.60 on 02/25/25 | 0.44 on 02/20/25 | ||
| Latest Earnings Date | 02/19/25 | 05/07/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.70 | 103.25 | ||